Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 4, 2000, Pages 577-582

  Cirioni, Oscar ^a,b   Giacometti, Andrea ^a   Barchiesi, Francesco ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE LACTOFERRIN; CLARITHROMYCIN; COTRIMOXAZOLE; HUMAN LACTOFERRIN; IRON CHELATING AGENT; LACTOFERRIN; MINOCYCLINE; PYRIMETHAMINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYST; DILUTION; DRUG POTENTIATION; DRUG SENSITIVITY; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LUNG ALVEOLUS EPITHELIUM; MONOLAYER CULTURE; NONHUMAN; PARASITE ISOLATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; TROPHOZOITE;

EID: 0033789005     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.4.577     Document Type: Article

References (32)

1. Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs
2. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection
3. Pneumocystis carinii pneumonia in patients without AIDS
4. A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents
5. Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: Analysis of drug interactions and efficacies
6. Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia
7. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii
8. Lactoferrin: A multifunctional immunoregulatory protein?
9. Lactoferrin: Molecular structure and biological function
10. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide
11. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin
12. Lactoferrin is a lipid A-binding protein
13. Innate antimicrobial activity of nasal secretions
14. Antibacterial effects of lactoferrin B
15. Lactoferricin, a new antimicrobial peptide
16. The structure of the antimicrobial active center of lactoferrin B bound to sodium dodecyl sulfate micelles
17. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs aginst clinical Candida isolates
18. In vitro susceptibility of Candida species to lactoferrin
19. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasis
20. Fungicidal effect of human lactoferrin against Candida albicans
21. Killing of Candida albicans by lactoferrin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
22. Elevated non-transferrin bound iron in the lungs of patients with Pneumocystis carinii pneumonia
23. Iron chelators as therapeutic agents against Pneumocystis carinii
24. Multiple iron chelators of diverse chemical classes are active against Pneumocystis carinii
25. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine
26. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole
27. Clindamycin-primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A randomized, double-blind pilot trial
28. Mutations in Pneumocystis carinii associated with prophylaxis breakthroughs in AIDS patients
29. Indicators of Pneumocystis carinii viability in short-term cell culture
30. The T.H. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immmunodeficiency virus and human cytomegalovirus replication in vitro
31. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease
32. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus